|
Quotes & Info
|
| LH > SEC Filings for LH > Form 8-K on 4-Aug-2009 | All Recent SEC Filings |
4-Aug-2009
Regulation FD Disclosure
On August 4, 2009, Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:
LH) announced that Andrew J. Conrad, Ph.D., Chief Scientist and David M.
Johnston, Ph.D., Vice President and Global Head of Clinical Trials, are
scheduled to speak at the William Blair & Company Personalized Medicine
Conference in New York. LabCorp's presentation is planned for Thursday, August
6, 2009.
Exhibits
99.1 Press Release dated August 4, 2009
|
|